Epidemiology of invasive meningococcal disease worldwide from 2010–2019: a literature review
CP de Santayana, MTT Htar, J Findlow… - Epidemiology & …, 2023 - cambridge.org
The epidemiology of invasive meningococcal disease (IMD) is unpredictable, varies by
region and age group and continuously evolves. This review aimed to describe trends in the …
region and age group and continuously evolves. This review aimed to describe trends in the …
Future directions for meningitis surveillance and vaccine evaluation in the meningitis belt of sub-Saharan Africa
RT Novak, O Ronveaux, AF Bita, HF Aké… - The Journal of …, 2019 - academic.oup.com
Abstract In sub-Saharan Africa, bacterial meningitis remains a significant public health
problem, especially in the countries of the meningitis belt, where Neisseria meningitidis …
problem, especially in the countries of the meningitis belt, where Neisseria meningitidis …
Empfehlungen der Ständigen Impfkommission (STIKO) und der Deutschen Gesellschaft für Tropenmedizin, Reisemedizin und Globale Gesundheit eV (DTG) zu …
Die STIKO empfiehlt Reiseimpfungen zum individuellen Schutz Reisender mit einem
Expositionsrisiko gegenüber bestimmten impfpräventablen Erkrankungen und um den …
Expositionsrisiko gegenüber bestimmten impfpräventablen Erkrankungen und um den …
Trends in Neisseria meningitidis serogroups amongst patients with suspected cerebrospinal meningitis in the meningitis belt of Ghana: a 5-year retrospective study
S Azure, A Abdul-Karim, BB Abubakari… - BMC Infectious …, 2023 - Springer
Abstract Background Serogroup A Neisseria meningitidis was the major cause of
meningococcal meningitis epidemics in the African meningitis belt before 2010 when the …
meningococcal meningitis epidemics in the African meningitis belt before 2010 when the …
Effect of biannual azithromycin to children under 5 years on the carriage of respiratory pathogens among children aged 7–11 years
SA Brennhofer, ETR McQuade, J Zhang… - … American Journal of …, 2022 - pmc.ncbi.nlm.nih.gov
In the MORDOR I trial, children under 5 years of age were randomized to receive biannual
(every 6 months) azithromycin for 2 years in Niger, Malawi, and Tanzania. In 30 Nigerien …
(every 6 months) azithromycin for 2 years in Niger, Malawi, and Tanzania. In 30 Nigerien …
Meningitis in Niger Republic amidst COVID-19: current issues and novel recommendations
MO Oduoye, HB Akanbi-Hakeem… - Annals of Medicine …, 2024 - journals.lww.com
Abstract Amidst coronavirus disease 2019 (COVID-19), there has been a misplaced priority
on meningitis in the Niger Republic, thus refocusing resources and attention away from the …
on meningitis in the Niger Republic, thus refocusing resources and attention away from the …
Neisseria meningitidis serogroup C clonal complex 10217 outbreak in West Kpendjal prefecture, Togo 2019
AR Feagins, AY Sadji, N Topaz, M Itsko… - Microbiology …, 2022 - Am Soc Microbiol
Togo has reported seasonal meningitis outbreaks caused by non-Neisseria meningitidis
serogroup A (NmA) pathogens since the introduction of meningococcal serogroup A …
serogroup A (NmA) pathogens since the introduction of meningococcal serogroup A …
Childhood meningitis in rural Gambia: 10 years of population-based surveillance
Background The introduction in many countries of conjugate vaccines against Haemophilus
influenzae type b, Streptococcus pneumoniae, and Neisseria meningitidis has led to …
influenzae type b, Streptococcus pneumoniae, and Neisseria meningitidis has led to …
Characterization of pneumococcal meningitis before and after introduction of 13-valent pneumococcal conjugate vaccine in Niger, 2010–2018
S Ousmane, M Kobayashi, I Seidou, B Issaka… - Vaccine, 2020 - Elsevier
Pneumococcal meningitis in the African meningitis belt is primarily caused by Streptococcus
pneumoniae serotype 1, a serotype contained in the 13-valent pneumococcal conjugate …
pneumoniae serotype 1, a serotype contained in the 13-valent pneumococcal conjugate …